TECH(Bio-Techne Corporation) · 财务报表

TECH(Bio-Techne Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-06-30FY 截至 2023-06-30FY 截至 2024-06-30FY 截至 2025-06-30FY 截至 2026-06-30
营业收入$1.11B$1.14B$1.16B$1.22B$1.22B
毛利润$756.50M$769.82M$769.73M$790.27M$799.07M
营业利润$296.59M$298.94M$206.69M$102.25M$251.89M
净利润$272.05M$285.26M$168.10M$73.40M$181.86M
经营现金流$325.27M$254.39M$298.98M$287.56M$292.07M
自由现金流$280.36M$216.15M$236.10M$256.55M$263.22M
摊薄每股收益$1.66$1.76$1.05$0.46$1.16

Bio-Techne Corporation TECH